ACER THERAPEUTICS INC's ticker is ACER and the CUSIP is 00444P108. A total of 31 filers reported holding ACER THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $43,786 | -10.6% | 53,035 | 0.0% | 0.00% | – |
| Q2 2023 | $48,973 | +17.6% | 53,035 | -3.4% | 0.00% | – |
| Q1 2023 | $41,661 | -84.9% | 54,925 | -50.0% | 0.00% | – |
| Q4 2022 | $275,724 | +884.7% | 109,850 | +443.1% | 0.00% | – |
| Q3 2022 | $28,000 | -6.7% | 20,225 | -13.8% | 0.00% | – |
| Q2 2022 | $30,000 | -59.5% | 23,465 | -8.2% | 0.00% | – |
| Q1 2022 | $74,000 | +29.8% | 25,565 | +2.4% | 0.00% | – |
| Q4 2021 | $57,000 | -10.9% | 24,965 | 0.0% | 0.00% | – |
| Q3 2021 | $64,000 | -9.9% | 24,965 | 0.0% | 0.00% | – |
| Q2 2021 | $71,000 | +91.9% | 24,965 | +94.3% | 0.00% | – |
| Q3 2020 | $37,000 | -37.3% | 12,849 | -25.6% | 0.00% | – |
| Q2 2020 | $59,000 | -78.3% | 17,259 | -87.4% | 0.00% | – |
| Q1 2020 | $272,000 | -39.1% | 136,735 | +22.5% | 0.00% | – |
| Q4 2019 | $447,000 | -6.9% | 111,579 | -25.8% | 0.00% | – |
| Q3 2019 | $480,000 | +22.1% | 150,466 | +49.4% | 0.00% | – |
| Q2 2019 | $393,000 | – | 100,736 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nantahala Capital Management | 934,755 | $2,673,000 | 0.08% |
| XTX Topco Ltd | 18,770 | $54,000 | 0.02% |
| Larson Financial Group LLC | 922 | $3,000 | 0.00% |
| BNP PARIBAS FINANCIAL MARKETS | 179 | $512,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 200 | $1,000 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 14,665 | $42,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 52 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 44 | $0 | 0.00% |
| NORTHERN TRUST CORP | 19,672 | $57,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |